Form 4: Bausch Health EVP, General Counsel Seana Carson Reports Share Transactions

Seana Carson, EVP and General Counsel of Bausch Health Companies Inc., reports acquisition of shares through restricted share units and subsequent disposals to cover tax obligations and sales under a 10b5-1 plan.

Summary

• Seana Carson, EVP, General Counsel of Bausch Health Companies Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 29, 2024, Carson acquired 147,536 common shares through restricted share units (RSUs) at $0, which vest in three annual installments.
• On March 1, 2024, Carson disposed of shares to cover tax withholding obligations related to the vesting of RSUs, with 765, 5,994, 16,973 and 511 shares sold at $9.89 each.
• From March 4, 2024, Carson sold shares in the open market under a pre-arranged Rule 10b5-1 plan, disposing of 4,420, 199, 1,561 and 133 shares at $9.8 each.
• Following these transactions, Carson beneficially owns 499,905 common shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The acquisition of RSUs is a positive sign, but the subsequent sales are likely for tax purposes and part of a pre-planned strategy. There's no clear indication of strong positive or negative sentiment.

Positives

• The acquisition of 147,536 shares through RSUs indicates confidence in the company's future.

Negatives

• The sale of shares to cover tax obligations and under a 10b5-1 plan could be perceived negatively, although it's a common practice.

Risks

• Sales under the 10b5-1 plan could continue, potentially exerting downward pressure on the stock price.

Future Outlook

The vesting schedule of the RSUs is one-third on each of the first three anniversaries following the date of grant, subject to continued service.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. Monitoring these filings can offer insights into management's perspective on the company's valuation and future prospects.

Comparison to Industry Standards

• Executives at comparable companies such as Johnson & Johnson and Novartis also routinely file Form 4s related to stock options, RSUs, and sales under 10b5-1 plans.
• The volume of shares traded by Seana Carson is within the typical range for executives at similarly sized companies.

Stakeholder Impact

• Shareholders may be interested in the insider trading activity as an indicator of management's confidence.
• The transactions have a minor impact on the overall share supply.

Key Dates